Does Osimertinib (Tagressa) need to be taken long-term?

Osimertinib is a targeted therapy drug that is commonly used to treat advanced non-small cell lung cancer (NSCLC) with EGFR (epidermal growth factor receptor) mutation-positive tumors. For most patients, osimertinib usually needs to be taken long-term. The following are some important considerations regarding long-term use of osimertinib:

1.Chronic nature of the disease:NSCLCis usually a chronic disease that requires long-term treatment and management. Even if osimertinib achieves good efficacy in the early stages of treatment, tumor cells may gradually develop drug resistance, leading to disease progression. Therefore, patients often need to continue receiving osimertinib or other treatments to control disease progression.

2.Maintaining efficacy: For those patients who are sensitive to osimertinib, long-term use will help maintain the efficacy of treatment. Continuous treatment can prevent the recurrence and spread of tumor cells and prolong the progression-free survival and overall survival of patients.

3.Development of drug resistance: Although osimertinib usually has good efficacy in the early stages of treatment, as treatment continues, some patients may develop drug resistance, leading to disease progression. In this case, patients may need to switch or combine other treatments, but will still need long-term treatment to control the disease.

4.Clinical practice guidance: According to clinical practice guidance, osimertinib is generally considered an option for long-term maintenance treatment. Multiple clinical studies and clinical practice experience have shown that long-term use of osimertinib can effectively control the progression of the disease and improve patients' survival rate and quality of life.

In summary, osimertinib usually needs to be taken long-term to maintain its therapeutic efficacy and control the progression of non-small cell lung cancer. Patients should pay close attention to the treatment effects and adverse reactions during treatment, and conduct continuous monitoring and management according to the doctor's advice and guidance.